Primary anetoderma

Primary anetoderma (also known as primary macular atrophy or anetoderma maculosa) is a rare dermatological condition characterized by circumscribed areas of slack, wrinkled, or pouch-like skin resulting from a localized loss of elastic tissue in the dermis. The term 'anetoderma' derives from the Greek word 'anetos,' meaning relaxed. In primary anetoderma, these skin changes arise without any identifiable preceding inflammatory or other dermatological condition, distinguishing it from secondary anetoderma, which occurs at sites of prior skin disease. The condition primarily affects the skin, most commonly on the trunk, upper arms, and thighs, though lesions can appear elsewhere. Clinically, patients develop soft, well-demarcated, round or oval patches or small outpouchings of skin that can be easily indented with finger pressure, sometimes described as 'buttonhole' herniation. Lesions typically range from 1 to 2 centimeters in diameter and may be skin-colored, whitish, or slightly bluish. Two classical subtypes have been described historically: the Jadassohn-Pellizzari type, which is preceded by an inflammatory (erythematous or urticarial) phase, and the Schweninger-Buzzi type, which appears without preceding inflammation. The condition is generally benign and asymptomatic, though it can be cosmetically distressing. Primary anetoderma has been associated in some cases with autoimmune conditions, antiphospholipid antibodies, or other systemic disorders, so evaluation for underlying conditions may be warranted. There is no consistently effective treatment for primary anetoderma. The loss of elastic fibers is generally considered irreversible once established. Management is largely supportive and cosmetic. Some reports have described attempts with dapsone, colchicine, or other anti-inflammatory agents during the early inflammatory phase to potentially limit progression, but evidence remains limited and anecdotal. Surgical excision of individual bothersome lesions may be considered in select cases. Patients are advised to undergo screening for associated autoimmune conditions, particularly antiphospholipid syndrome.

Common questions about Primary anetoderma